Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple-Masked, Placebo-Controlled Clinical Trial

Por Langley, Blake O., Ryan, Jennifer Joan, Hanes, Douglas, Phipps, John, Stack, Emily, Metz, Thomas O., Stevens, J. Frederik, Bradley, Ryan
Publicado no Mol Nutr Food Res (2021)

Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial

Por Bradley, Ryan, Langley, Blake O., Ryan, Jennifer J., Phipps, John, Hanes, Douglas A., Stack, Emily, Jansson, Janet K., Metz, Thomas O., Stevens, Jan Frederik
Publicado no Trials (2020)

Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial

Por Bradley, Ryan, Langley, Blake O., Ryan, Jennifer J., Phipps, John, Hanes, Douglas A., Stack, Emily, Jansson, Janet K., Metz, Thomas O., Stevens, Jan Frederik
Publicado no Trials (2020)

Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial

Por Fitzgerald, Kara N., Hodges, Romilly, Hanes, Douglas, Stack, Emily, Cheishvili, David, Szyf, Moshe, Henkel, Janine, Twedt, Melissa W., Giannopoulou, Despina, Herdell, Josette, Logan, Sally, Bradley, Ryan
Publicado no Aging (Albany NY) (2021)